Immatics at European Neoantigen Summit 2018 (Apr 24-26) in Amsterdam, The Netherlands

| News

Immatics is a part of the European Neoantigen Summit 2018 in Amsterdam - come and join our CTO Toni Weinschenk's talk and panel presentation: 


Talk: “Personalised Onco-Immunotherapy: in vivo and ex vivo Vaccination Trials“

April 26th, 10.45am

Track: Advancing Cell & Vaccine-based Therapies

Speaker: Toni Weinschenk (CTO)


Panel: “Maximizing the Potential of Neoantigen-based Targeting for Cancer Vaccines

April 26th, 11.45am

Panelist Immatics: Toni Weinschenk (CTO)


We're looking forward to interesting and exciting discussions. See the full Summit agenda here

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.